Evidence map›Paper›PMID 29065193›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2018

The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette Smokers.

Will Lawn, Tom P Freeman, Katie East, Annie Gaule, Elizabeth R Aston, Michael A P Bloomfield, Ravi K Das, Celia J A Morgan, H Valerie Curran

Open access · hybridAbstract readControlled Clinical Trial
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Disentangling the effects of cannabis and cigarette smoking on impulsivity.Journal of psychopharmacology (Oxford, England) · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Will LawnClinical Psychopharmacology unit, University College London, London, UK.
Tom P FreemanClinical Psychopharmacology unit, University College London, London, UK.
Katie EastAddictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Annie GauleClinical Psychopharmacology unit, University College London, London, UK.
Elizabeth R AstonCenter for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI.
Michael A P BloomfieldClinical Psychopharmacology unit, University College London, London, UK.
Ravi K DasClinical Psychopharmacology unit, University College London, London, UK.
Celia J A MorganClinical Psychopharmacology unit, University College London, London, UK.
H Valerie CurranClinical Psychopharmacology unit, University College London, London, UK.
University College London · GBBrown University · USKing's College London · GBMedical Research Council · GBSinger (United States) · US

Funding

Behavioral Economic Analysis of Demand for MarijuanaK01DA039311 · NIDA · BROWN UNIVERSITY · PI ASTON, ELIZABETH · 2015 to 2019
$902k
Biotechnology and Biological Sciences Research CouncilMedical Research Council MR/K023195/1NIDA NIH HHS K01 DA039311
6 · The paper itself

Abstract

Background: Dopaminergic functioning is thought to play critical roles in both motivation and addiction. There is preliminary evidence that dopamine agonists reduce the motivation for cigarettes in smokers. However, the effects of pramipexole, a dopamine D3 receptor preferring agonist, have not been investigated. The aim of this study was to examine the effects of an acute dose of pramipexole on the motivation to earn cigarettes and nondrug rewards. Methods: Twenty dependent and 20 occasional smokers received 0.5 mg pramipexole using a double-blind, placebo-controlled crossover design. Motivation for cigarettes and consummatory nondrug rewards was measured using the DReaM-Choice task, in which participants earned, and later "consumed," cigarettes, music, and chocolate. Demand for cigarettes was measured using the Cigarette Purchase Task (CPT). Self-reported craving, withdrawal, and drug effects were also recorded. Results: Dependent smokers chose (p < .001) and button-pressed for (p < .001) cigarettes more, and chose chocolate less (p < .001), than occasional smokers. Pramipexole did not affect the number of choices for or amount of button-pressing for any reward including cigarettes, which was supported by a Bayesian analysis. The dependent smokers had greater demand for cigarettes than occasional smokers across all CPT outcomes (ps < .021), apart from elasticity. Pramipexole did not affect demand for cigarettes, and this was supported by Bayesian analyses. Pramipexole produced greater subjective "feel drug" and "dislike drug" effects than placebo. Conclusions: Dependent and occasional cigarette smokers differed in their motivation for cigarettes but not for the nondrug rewards. Pramipexole did not acutely alter motivation for cigarettes. These findings question the role of dopamine D3 receptors in cigarette-seeking behavior in dependent and occasional smokers. Implications: This study adds to the growing literature about cigarette versus nondrug reward processing in nicotine dependence and the role of dopamine in cigarette-seeking behavior. Our results suggest nicotine dependence is associated with a hypersensitivity to cigarette rewards but not a hyposensitivity to nondrug rewards. Furthermore, our results question the importance of dopamine D3 receptors in motivational processing of cigarettes in occasional and dependent smokers.

Indexed as

AdultBehavior, AddictiveCigarette SmokingCravingCross-Over StudiesDopamine AgonistsDouble-Blind MethodFemaleHumansMaleMotivationPramipexoleReceptors, Dopamine D3Tobacco Use DisorderYoung AdultDopamine AgonistsPramipexoleReceptors, Dopamine D3

Identifiers

PMID29065193
PMCPMC5991206
OpenAlexW2735457852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.